Arvin Yang Mersana Therapeutics, Inc. (MRSN) insider trading activity

MRSN Quotes by TradingView

Arvin Yang is SVP, Chief Medical Officer of Mersana Therapeutics, Inc.. Currently has a direct ownership of 30,821 shares of MRSN, which is worth approximately $57,327. The most recent transaction as insider was on Jan 17, 2023, when has been sold 2,209 shares (Common Stock) at a price of $5.74 per share, resulting in proceeds of $12,679. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.8K
0% 3M change
0% 12M change
Total Value Held $57,327

Arvin Yang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2023
SELL
Open market or private sale
$12,679 $5.74 p/Share
2,209 Reduced 6.69%
30,821 Common Stock
Jan 14 2023
BUY
Exercise of conversion of derivative security
-
7,084 Added 17.66%
33,030 Common Stock
Dec 01 2022
SELL
Open market or private sale
$36,422 $6.59 p/Share
5,527 Reduced 17.56%
25,946 Common Stock
Nov 30 2022
BUY
Exercise of conversion of derivative security
-
18,500 Added 37.02%
31,473 Common Stock
Dec 01 2021
SELL
Open market or private sale
$37,639 $6.81 p/Share
5,527 Reduced 29.88%
12,973 Common Stock
Nov 30 2021
BUY
Exercise of conversion of derivative security
-
18,500 Added 50.0%
18,500 Common Stock
AY

Arvin Yang

SVP, Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRSN